Condition
Essential Tremor, Movement Disorders clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Essential Tremor, Movement Disorders clinical trials that are recruiting, at sites in 2 countries (most in United States (4), Canada (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Essential Tremor, Movement Disorders clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Skin biopsy test for phosphorylated alpha‑synuclein to find which essential tremor patients are at risk for Parkinson's disease | — | Scottsdale, Arizona and 10 other locations | Recruiting | Feb 23, 2026 |
| Long-term outcomes after MRI-guided focused ultrasound thalamotomy for medication-resistant essential tremor | — | Toronto, Ontario | Recruiting | Oct 8, 2025 |
| Stimulating the motor thalamus and surface cortex to improve movement and speech | — | Pittsburgh, Pennsylvania | Recruiting | Jul 9, 2025 |
| Motor thalamus deep brain stimulation to improve movement and speech | — | Pittsburgh, Pennsylvania | Recruiting | Jul 9, 2025 |
| Nighttime-adaptive deep brain stimulation for essential tremor | — | Gainesville, Florida | Recruiting | Oct 10, 2024 |
All recruiting trials (5)
-
Skin biopsy test for phosphorylated alpha‑synuclein to find which essential tremor patients are at risk for Parkinson's disease
This uses a small skin biopsy (Syn‑One) to see if phosphorylated alpha‑synuclein can identify people aged 50–85 with essential tremor who are more likely to develop Parkinson's disease.
-
Long-term outcomes after MRI-guided focused ultrasound thalamotomy for medication-resistant essential tremor
This project will see if MRI-guided focused ultrasound thalamotomy provides lasting tremor relief and good long-term safety for people whose essential tremor has not responded to medications.
-
Stimulating the motor thalamus and surface cortex to improve movement and speech
This test tries brief electrical stimulation of the motor thalamus (VOP/VIM) and nearby cortex during DBS surgery to see if it improves movement, grip strength, and speech in people having DBS for Parkinson's disease, essential tremor, stroke, or brain injury.
-
Motor thalamus deep brain stimulation to improve movement and speech
This trial will test turning deep brain stimulation on and off in adults who already have DBS implants for movement disorders to see if stimulation improves arm and hand movement, facial movement, speech, and swallowing.
-
Nighttime-adaptive deep brain stimulation for essential tremor
We will test whether using each patient’s thalamic sleep-related brain signals to automatically turn DBS off at night can reduce side effects while keeping tremor under control in people with essential tremor who already have Medtronic Percept implants.
Related topics
Quick answers
How many Essential Tremor, Movement Disorders clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (4 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.